Drug Profile
NSC 638242
Latest Information Update: 06 Jul 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 06 Jul 1998 Profile reviewed
- 06 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 24 Apr 1995 Preclinical development for Cancer in USA (Unknown route)